46579 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 08
18:56 UTC
|
CBSH
Commerce Bancshares
|
↑ Upgrade | Manan Gosalia ★★★☆☆ #2083 | Positive→ Overweight | $65.00→ $76.00+16.9% |
|
Sep 08
17:56 UTC
|
XPO
XPO
|
◎ Target | Ariel Rosa ★★☆☆☆ #2742 | Neutral | $221.00→ $220.00-0.5% |
|
Sep 08
17:56 UTC
|
TH
Target Hospitality
|
◎ Target | Scott Schneeberger ★★★☆☆ #1124 | Outperform | $24.00→ $27.00+12.5% |
|
Sep 08
17:56 UTC
|
SAIA
Saia
|
◎ Target | Ariel Rosa ★★☆☆☆ #2742 | Buy | $423.00→ $417.00-1.4% |
|
Sep 08
17:56 UTC
|
ROIV
Roivant Sciences
|
◎ Target | Douglas Tsao ★★☆☆☆ #2436 | Buy | $41.00→ $47.00+14.6% |
|
Sep 08
17:56 UTC
|
HOG
Harley-Davidson
|
◎ Target | James Hardiman ★★☆☆☆ #2460 | Neutral | $27.00→ $31.00+14.8% |
|
Sep 08
17:56 UTC
|
EGAN
eGain
|
◎ Target | Erik Suppiger ★★☆☆☆ #2467 | Neutral | $10.50→ $6.00-42.9% |
|
Sep 08
17:56 UTC
|
DGX
Quest Diagnostics
|
◎ Target | Kevin Caliendo ★★★☆☆ #1156 | Neutral | $232.00→ $245.00+5.6% |
|
Sep 08
17:56 UTC
|
CLYM
Climb Bio
|
◎ Target | Leland Gershell ★★★☆☆ #1004 | Outperform | $18.00→ $25.00+38.9% |
|
Sep 08
17:56 UTC
|
PTON
Peloton Interactive
|
↓ Downgrade | Lauren Schenk not yet tracked | Equal Weight→ Underweight | $5.00→ $4.50-10.0% |
|
Sep 08
17:56 UTC
|
EGAN
eGain
|
↓ Downgrade | Richard Baldry ★★★★☆ #764 | Buy→ Neutral | $21.00→ $7.00-66.7% |
|
Sep 08
17:56 UTC
|
INTC
Intel
|
↑ Upgrade | Gus Richard ★★★☆☆ #1878 | Market Perform→ Outperform | $120.00 |
|
Sep 08
16:55 UTC
|
VERA
Vera Therapeutics
|
◎ Target | Anupam Rama ★★★☆☆ #1866 | Overweight | $76.00→ $83.00+9.2% |
|
Sep 08
16:55 UTC
|
UDR
United Dominion Realty Trust
|
◎ Target | Vikram Malhorta not yet tracked | Neutral | $41.00→ $39.00-4.9% |
|
Sep 08
16:55 UTC
|
ROIV
Roivant Sciences
|
◎ Target | Dennis Ding ★★★☆☆ #1892 | Buy | $42.00→ $52.00+23.8% |
|
Sep 08
16:55 UTC
|
HOOD
Robinhood Markets
|
◎ Target | Daniel Fannon ★★★★☆ #408 | Buy | $127.00→ $140.00+10.2% |
|
Sep 08
16:55 UTC
|
FDX
FedEx
|
◎ Target | Brian Ossenbeck ★★☆☆☆ #2364 | Overweight | $460.00→ $400.00-13.0% |
|
Sep 08
16:55 UTC
|
CPT
Camden Property Trust
|
◎ Target | Vikram Malhorta not yet tracked | Outperform | $125.00→ $116.00-7.2% |
|
Sep 08
16:55 UTC
|
ODFL
Old Dominion Freight Line
|
↑ Upgrade | Ariel Rosa ★★☆☆☆ #2742 | Neutral→ Buy | $231.00→ $223.00-3.5% |
|
Sep 08
16:55 UTC
|
CHRW
C.H. Robinson Worldwide
|
↑ Upgrade | Ariel Rosa ★★☆☆☆ #2742 | Neutral→ Buy | $196.00→ $185.00-5.6% |
|
Sep 08
16:55 UTC
|
ABNB
Airbnb
|
↑ Upgrade | Josh Beck ★☆☆☆☆ #2932 | Market Perform→ Outperform | $200.00 |
|
Sep 08
15:55 UTC
|
PTON
Peloton Interactive
|
◎ Target | Arpine Kocharyan ★★☆☆☆ #2359 | Buy | $11.00→ $10.00-9.1% |
|
Sep 08
15:55 UTC
|
MPC
Marathon Petroleum
|
◎ Target | Manav Gupta ★★★★☆ #797 | Buy | $321.00→ $450.00+40.2% |
|
Sep 08
15:55 UTC
|
MAA
Mid-America Apartment Communities
|
◎ Target | Haendel St. Juste ★★★☆☆ #1702 | Outperform | $152.00→ $140.00-7.9% |
|
Sep 08
15:55 UTC
|
IONS
Ionis Pharmaceuticals
|
◎ Target | Mitchell Kapoor ★★☆☆☆ #2691 | Buy | $115.00→ $100.00-13.0% |
|
Sep 08
15:55 UTC
|
HYPD
Hyperion DeFi
|
◎ Target | James McIlree ★☆☆☆☆ #2985 | Buy | $7.30→ $8.45+15.8% |
|
Sep 08
15:55 UTC
|
ALNY
Alnylam Pharmaceuticals
|
◎ Target | Faisal Khurshid ★★★★★ #62 | Hold | $230.00→ $260.00+13.0% |
|
Sep 08
15:55 UTC
|
PHR
Phreesia
|
↓ Downgrade | John Ransom ★★★☆☆ #993 | Outperform→ Market Perform | |
|
Sep 08
15:55 UTC
|
INTC
Intel
|
↑ Upgrade | Timothy Arcuri ★★☆☆☆ #2276 | Neutral→ Buy | |
|
Sep 08
15:55 UTC
|
HCM
HUTCHMED
|
↑ Upgrade | firm only | Hold→ Buy | |
|
Sep 08
15:55 UTC
|
FDS
FactSet Research Systems
|
↑ Upgrade | Andrew Nicholas ★★★★☆ #527 | Market Perform→ Outperform | |
|
Sep 08
14:55 UTC
|
VRSK
Verisk Analytics
|
◎ Target | Manav Patnaik ★★★☆☆ #2207 | Overweight | $275.00→ $225.00-18.2% |
|
Sep 08
14:55 UTC
|
VLO
Valero Energy
|
◎ Target | Manav Gupta ★★★★☆ #797 | Buy | $355.00→ $450.00+26.8% |
|
Sep 08
14:55 UTC
|
TRI
Thomson Reuters
|
◎ Target | Manav Patnaik ★★★☆☆ #2207 | Overweight | $140.00→ $130.00-7.1% |
|
Sep 08
14:55 UTC
|
SYM
Symbotic
|
◎ Target | Guy Hardwick ★★★☆☆ #1939 | Underweight | $44.00→ $38.00-13.6% |
|
Sep 08
14:55 UTC
|
SNX
TD SYNNEX
|
◎ Target | Guy Hardwick ★★★☆☆ #1939 | Equal Weight | $278.00→ $287.00+3.2% |
|
Sep 08
14:55 UTC
|
SLG
SL Green Realty
|
◎ Target | Brendan Lynch ★★★☆☆ #1751 | Equal Weight | $52.00→ $54.00+3.8% |
|
Sep 08
14:55 UTC
|
SAIC
Science Applications International
|
◎ Target | Gavin Parsons ★★★☆☆ #2133 | Sell | $93.00→ $103.00+10.8% |
|
Sep 08
14:55 UTC
|
RPRX
Royalty Pharma
|
◎ Target | Michael Nedelcovych ★★★☆☆ #1587 | Buy | $65.00→ $68.00+4.6% |
|
Sep 08
14:55 UTC
|
PSX
Phillips 66
|
◎ Target | Manav Gupta ★★★★☆ #797 | Buy | $235.00→ $300.00+27.7% |
|
Sep 08
14:55 UTC
|
NOC
Northrop Grumman
|
◎ Target | Gavin Parsons ★★★☆☆ #2133 | Buy | $685.00→ $704.00+2.8% |
|
Sep 08
14:55 UTC
|
MANH
Manhattan Associates
|
◎ Target | Guy Hardwick ★★★☆☆ #1939 | Overweight | $201.00→ $239.00+18.9% |
|
Sep 08
14:55 UTC
|
JBL
Jabil
|
◎ Target | Mark Delaney ★★★☆☆ #2184 | Buy | $482.00→ $375.00-22.2% |
|
Sep 08
14:55 UTC
|
IRM
Iron Mountain
|
◎ Target | Brendan Lynch ★★★☆☆ #1751 | Overweight | $143.00→ $144.00+0.7% |
|
Sep 08
14:55 UTC
|
IONS
Ionis Pharmaceuticals
|
◎ Target | Salveen Richter ★★★☆☆ #1856 | Neutral | $69.00→ $56.00-18.8% |
|
Sep 08
14:55 UTC
|
HOOD
Robinhood Markets
|
◎ Target | James Yaro ★★☆☆☆ #2576 | Buy | $124.00→ $142.00+14.5% |
|
Sep 08
14:55 UTC
|
GD
General Dynamics
|
◎ Target | Gavin Parsons ★★★☆☆ #2133 | Neutral | $395.00→ $408.00+3.3% |
|
Sep 08
14:55 UTC
|
EQIX
Equinix
|
◎ Target | Brendan Lynch ★★★☆☆ #1751 | Equal Weight | $1,130.00→ $1,135.00+0.4% |
|
Sep 08
14:55 UTC
|
DINO
HF Sinclair
|
◎ Target | Manav Gupta ★★★★☆ #797 | Buy | $105.00→ $126.00+20.0% |
|
Sep 08
14:55 UTC
|
DG
Dollar General
|
◎ Target | Seth Sigman ★★★☆☆ #1737 | Overweight | $148.00→ $151.00+2.0% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.